In-vitro fertilization (IVF) Market 2021-2030 By Industry Size, Growth Rate, Market Insight, Target Audience, Competition and Forecast

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4  billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for In-vitro fertilization (IVF) Market products.

Moreover, the median health expenditure per capita recorded in the high-income, upper-middle income, and low & lower-middle income countries, recorded to be over USD 2,000, USD 400, and USD 100 respectively. Additionally, in the same year, the spending on health in high-income countries and in the low- and middle-income countries comprised approximately 8.2% and 6.3% of the GDP respectively.

“Final Report will add the analysis of the impact of COVID-19 on this industry.”

Global In-vitro fertilization (IVF) Market was valued at USD 508 Million in the year 2017. Global In-vitro fertilization (IVF) Market is further estimated to grow at a CAGR of 10.4 % from 2019 to reach USD 1121.51 Million by the year 2025. North America region holds the highest Market share in 2017 and Europe is considered as the fastest growing Market in the forecasted period. At country level, developed industries U.S holds a substantial Market share in 2017 and it is projected to grow at a gradual pace in the coming years.

Major market players in In-Vitro Fertilization (IVF) Market are OvaScience, EMD Serono Inc., Irvine Scientific, CooperSurgical Inc., Vitrolife AB, Cook Medical Inc., Progyny Inc., Genea Biomedx, Boston IVF, Kitazato Corp, and other brief information of 10 companies will be provided in report. Rising research and development expenses to address the changing demand of end users, similarly growth strategies such as acquisition, merger and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10078312

SWOT Analysis of IN-Vitro Fertilization (IVF) Market:
Strength:

Declining fertility rate
Increasing incidences of male and female infertility
Weakness:

High Cost and Low Success Rate of the IVF Treatment
Lack of regulatory framework
Opportunities:
Availability of supportive government funding
Fertility Tourism
Threats:
Reducing Efficacy of Infertility Treatment with Advancing Age
Ethical considerations

The global in-vitro fertilization (IVF) Market id segmented on the basis of types of cycle, by application and by region. On the basis of types of cycle the Market is segmented as Fresh Cycle (Non-Donor), Thawed IVF Cycle (Non-Donor) and Donor Egg IVF Cycle of which Fresh Cycle (Non-Donor) segment is expected to hold the highest Market share during the forecast period.
On the basis of application the Market is segmented as Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes, in which Fertility Clinics holds the highest Market share.

In-Vitro Fertilization (IVF) Market:
By Types of cycle

• Fresh Cycle (Non-Donor)
• Thawed IVF Cycle (Non-Donor)
• Donor Egg IVF Cycle

By Application
• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes

By Region
• North America
o USA
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Rest of Europe
• APAC
o China
o India
o Japan
o Rest of Asia-Pacific
• RoW
o Latin America
o Middle East & Africa

1. Introduction
1.1 Industry Vision
1.2 Limitations
1.3 Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.1.1. Key Data from Secondary Research
2.1.2. Primary Research
2.1.2.1. Key Data from Primary Research
2.1.2.2. Breakdowns of Primary Interviews
2.2. Industry Size Estimation
2.2.1. Bottoms-Up Approach
2.2.2. Top-Down Approach
2.2.3. Annual Revenue Process
2.3. Data Triangulation
2.4. Research Assumptions
2.4.1. Assumption
3. Executive Summary
4. Industry Overview
4.1. Introduction
4.2. Strength
4.3. Weakness
4.4. Opportunities
4.5. Threats
4.6. Regulations
4.7. Supply Chain/Value Chain Analysis
4.8. Patent & Standards
5. Industry Trends
5.1. Introduction
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Buyers
5.2.4. Bargaining Power of Suppliers
5.2.5. Intensity of Competitive Rivalry
6. In-vitro fertilization (IVF) Industry, By Types of cycle
6.1. Fresh Cycle (Non-Donor)
6.2 Thawed IVF Cycle (Non-Donor)
6.3 Donor Egg IVF Cycle
7. In-vitro fertilization (IVF) Industry, By Application
7.1. Fertility Clinics
7.2 Hospitals
7.3 Surgical Centers
7.4 Clinical Research Institutes
8 Geographical Analysis
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. RoE
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. RoAPAC
8.5. RoW
8.5.1. Latin America
8.5.1.1. Brazil
8.5.1.2. Argentina
8.5.1.3. Rest of Latin America
8.5.2. Middle East and Africa
9. Company Profiles
9.1. OvaScience
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Overview
9.1.4 Current Development
9.2 EMD Serono, Inc.
9.3 Irvine Scientific
9.4 CooperSurgical, Inc.
9.5 Vitrolife AB
9.6 Cook Medical, Inc.
9.7 Progyny, Inc.
9.8 Genea Biomedx
9.9 Boston IVF
9.10 Kitazato Corporation
10. Competitive Analysis
10.1. Introduction
10.2. Industry Positioning of Key Players
10.3 Competitive Strategies Adopted by Leading Players
10.3.1. Investments & Expansions
10.3.2. New Product Launches
10.3.3. Mergers & Acquisitions
10.3.4. Agreements, Joint Ventures, and Partnerships
11. Appendix
11.1. Questionnaire
11.2. Available Customizations
11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)”

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0Shares